Age and laterality of children should be considered when determining IOL power

Article

A child's age and laterality are important factors to consider when determining intraocular lens (IOL) power.

A study featured in the British Journal of Ophthalmology has shown that a child's age and laterality are important factors to consider when determining intraocular lens (IOL) power.

A team lead by Dr R. Wolfs, Erasmus University Medical Center, Department of Ophthalmology, The Netherlands, investigated the amount of myopic shift in children after catract surgery with IOL implantation. The children were split into three groups according to their age. Group A consisted of 0–1 year olds, Group B, 1–7 year olds and Group C, 7–18 year olds. Expected myopic shift was calculated using a formula created by multiple regression analysis. Variables linked with a higher prediction area were also calculated.

Children aged 12 months and under presented with higher myopic shifts and a bigger mean rate of refractive change per year. Higher myopic shifts were also found in children with unilateral cataract. Group A experienced a significantly higher absolute prediction error compared to Group B and Group C.

The results demonstrate that predicting the postoperative refraction in children under 1 years old is complex and factors such as age and laterality need to be considered.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.